We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$663M
AUM Growth
+$82.4M
Cap. Flow
+$53.8M
Cap. Flow %
8.11%
Top 10 Hldgs %
13.93%
Holding
946
New
109
Increased
498
Reduced
262
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 13.89%
2 Healthcare 13.32%
3 Financials 12.03%
4 Industrials 11.79%
5 Consumer Discretionary 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBBN icon
851
Ribbon Communications
RBBN
$354M
$86K 0.01%
+4,796
New +$81.1K
SD
852
DELISTED
SANDRIDGE ENERGY, INC.
SD
$73K 0.01%
10,247
-853
-8% -$5.74K
OREX
853
DELISTED
Orexigen Therapeutics, Inc.
OREX
$70K 0.01%
1,135
-11
-1% -$640
CIM
854
Chimera Investment
CIM
$1.05B
$68K 0.01%
1,420
-158
-10% -$7.43K
EXEL icon
855
Exelixis
EXEL
$13.9B
$64K 0.01%
18,997
-813
-4% -$2.81K
RTK
856
DELISTED
Rentech, Inc.
RTK
$58K 0.01%
2,222
-112
-5% -$2.5K
FCEL icon
857
FuelCell Energy
FCEL
$1.7B
$51K 0.01%
5
CGRN
858
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$48K 0.01%
160
+3
+2% +$1.03K
ZNGA
859
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$48K 0.01%
14,974
+1,245
+9% +$4.5K
ARRY
860
DELISTED
Array Biopharma Inc
ARRY
$46K 0.01%
10,190
-2,591
-20% -$10.7K
SQNM
861
DELISTED
SEQUENOM INC NEW
SQNM
$44K 0.01%
11,357
-542
-5% -$1.58K
CTIC
862
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$37K 0.01%
1,309
-33
-2% -$992
DNDN
863
DELISTED
DENDREON CORPORATION
DNDN
$36K 0.01%
15,608
-679
-4% -$1.59K
RXII
864
DELISTED
GALENA BIOPHARMA INC COM
RXII
$35K 0.01%
11,516
-451
-4% -$1.37K
LXRX icon
865
Lexicon Pharmaceuticals
LXRX
$1.02B
$33K 0.01%
2,903
-250
-8% -$2.69K
CDMO
866
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$30K ﹤0.01%
2,309
-264
-10% -$3.33K
ATRS
867
DELISTED
Antares Pharma, Inc.
ATRS
$30K ﹤0.01%
11,390
-259
-2% -$780
ZGNX
868
DELISTED
Zogenix, Inc.
ZGNX
$24K ﹤0.01%
1,490
+218
+17% +$3.94K
NAVB
869
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$17K ﹤0.01%
589
+51
+9% +$1.65K
QMCO icon
870
Quantum Corp
QMCO
$437M
$13K ﹤0.01%
+64
New +$11.7K
ACGL icon
871
Arch Capital
ACGL
$36.1B
-11,235
Closed -$215K
AEO icon
872
American Eagle Outfitters
AEO
$2.85B
-16,259
Closed -$199K
APTV icon
873
Aptiv
APTV
$12B
-7,921
Closed -$538K
ATR icon
874
AptarGroup
ATR
$8.45B
-6,001
Closed -$397K
AXS icon
875
AXIS Capital
AXS
$8.59B
-5,098
Closed -$234K

Similar funds

Amalgamated Bank's Q2 2014 Portfolio in Review

As of Q2 2014, Amalgamated Bank held 946 positions worth $663M, up 14% from $580M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Amalgamated Bank deployed $53.8M of net new capital in Q2 2014, opening 109 new positions and adding to 498 existing holdings. Its largest new stake was Harman International Industries: 7,795 shares worth $837K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Cheniere Energy, an estimated $1.33M trimmed.

  • Amalgamated Bank's largest Q2 2014 buy was Harman International Industries: 7,795 shares worth $837K.
  • Amalgamated Bank added most to iShares Russell 3000 ETF in Q2 2014, an estimated $5.95M increase.
  • Amalgamated Bank's biggest Q2 2014 reduction was Cheniere Energy, cutting an estimated $1.33M.
  • Amalgamated Bank fully exited TransDigm Group in Q2 2014, selling an estimated $1.09M.
  • Amalgamated Bank's ten largest holdings make up 14% of its $663M portfolio in Q2 2014.
  • Amalgamated Bank opened 109 new positions and closed 75 in Q2 2014.
  • Amalgamated Bank's portfolio value rose 14% quarter-over-quarter to $663M.

Based on Amalgamated Bank's 13F filing for Q2 2014, filed 11 Aug 2014.